Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2026-02-20 @ 12:38 PM
Study NCT ID:
NCT02225132
Status:
COMPLETED
Last Update Posted:
2019-08-06
First Post:
2014-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Assessment of Algorithm-Based Hydroxyurea Dosing on Fetal Hemoglobin Response, Acute Complications, and Organ Function in People With Sickle Cell Disease
Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
140172
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None